Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Rosuvastatin on Vitamin D in ACS
NCT06765265Phase 4Recruiting
- Sponsor
- King Edward Medical University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in acute coronary syndrome (ACS), sponsored by King Edward Medical University. Started Jan 2025; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06765265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765265.